Sumitomo Mitsui Financial Group (TYO:8316) and its wholly owned subsidiary Sumitomo Mitsui Banking Corporation (SMBC) jointly established GoAhead Pitch, a video pitch platform, with Silicon Valley-based venture capital firm GoAhead Ventures.
GoAhead Pitch was launched in February, according to a Tokyo bourse filing on Monday.
GoAhead Fund III, a Delaware limited partnership, invested in AOI Biosciences via GoAhead Pitch. AOI Biosciences develops the β2GPI Neoself Antibody Test and supports the development of diagnostics and therapies targeting autoimmune diseases.